Brief: Seres Therapeutics Reports Q3 2024 Financial Results And Provides Business Updates
13/11/2024 13:10
Nov 13 (Reuters) - Seres Therapeutics Inc MCRB.O :
* SERES THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* SERES THERAPEUTICS INC: CO EXPECTS TO FUND OPERATIONS
INTO Q4
2025
* SERES THERAPEUTICS INC: EXISTING CASH TO FUND OPERATIONS
INTO
Q4 2025
Source text: urn:newsml:reuters.com:*:nGNX1nMBP
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47